Devices › Device types
FDA product code DXN · class 2 · Cardiovascular
System, measurement, blood-pressure, non-invasive: medical device reports filed with FDA
3,560 reports carry this product code, 1992–2026; 9 brands with a page.
- 3,560
- reports with this product code
- 0% of all MAUDE reports
- 1,157
- reports, 12 months to August 2026
- 336 in the 12 months before
- 88.7%
- classified as malfunction
- 62.3% across all reports
- 0.4%
- classified as death, as reported
- 0.9% across all reports
Product code DXN is FDA's classification for "System, measurement, blood-pressure, non-invasive" (cardiovascular panel), a class 2 device. 3,560 medical device reports carry this product code, 0% of the MAUDE database, from August 1992 to August 2026.
1,157 reports arrived in the 12 months to August 2026, up 244% from 336 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (88.7%), injury (8.4%) and other (1.3%). 9 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Safedraw | 268 | 85 | 0% | 97.7% |
| Vs4 Vital Signs Monitor | 164 | 0 | 0.6% | 99.4% |
| Ihealth | 6 | 13 | 0% | 98.3% |
| Panorama Central Station With Telepack | 5 | 0 | 0% | 99.7% |
| Datascope | 2 | 0 | 7.3% | 40.2% |
| Power cord 110V | 2 | 93 | 0% | 98.4% |
| Atlas | 1 | 31 | 0% | 96.1% |
| Braun | 1 | 24 | 0.5% | 71.8% |
| Invacare | 1 | 0 | 17% | 27% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Medline Industries | 906 | 25.4% |
| Mhc Medical Products | 462 | 13% |
| Philips Medical Systems | 337 | 9.5% |
| Edwards Lifesciences | 68 | 1.9% |
| Mindray Ds USA | 66 | 1.9% |
| Philips North America | 34 | 1% |
| Welch Allyn | 23 | 0.6% |
| Nihon Kohden | 10 | 0.3% |
| Datascope | 8 | 0.2% |
| Spacelabs Healthcare | 8 | 0.2% |
| Alaris Medical Systems | 5 | 0.1% |
| Welch Allyn Protocol | 5 | 0.1% |
| Philips Goldway Shenzhen Industrial | 4 | 0.1% |
| Ge Medical Systems | 3 | 0.1% |
| Icu Medical | 2 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Incorrect, inadequate or imprecise result or readings | 699 | 19.6% |
| Device operational issue | 391 | 11% |
| Fluid/blood leak | 343 | 9.6% |
| Device operates differently than expectedthe device behaved unexpectedly | 283 | 7.9% |
| Device displays incorrect message | 280 | 7.9% |
| Output problem | 260 | 7.3% |
| High readingsreadings were too high | 248 | 7% |
| Incorrect measurementthe device measured wrongly | 191 | 5.4% |
| Incorrect or inadequate test results | 177 | 5% |
| Inflation problem | 154 | 4.3% |
| High test results | 140 | 3.9% |
| Unable to obtain readings | 138 | 3.9% |
| Failure to power up | 116 | 3.3% |
| Low readingsreadings were too low | 98 | 2.8% |
| Image display error/artifact | 87 | 2.4% |
| Device provides uninformative message | 63 | 1.8% |
| Insufficient device problem information | 56 | 1.6% |
| No audible alarm | 51 | 1.4% |
| No audible prompt/feedback | 44 | 1.2% |
| Display or visual feedback problem | 42 | 1.2% |
Questions about system, measurement, blood-pressure, non-invasive reports
What is product code DXN?
FDA's classification code for "System, measurement, blood-pressure, non-invasive", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
3,560 reports through August 2026, 1,157 of them in the latest 12 months.
Which brands appear most often?
Safedraw (268), Vs4 Vital Signs Monitor (164), Ihealth (6), Panorama Central Station With Telepack (5) and Datascope (2). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.